Cargando…
Deficiency of macrophage migration inhibitory factor attenuates tau hyperphosphorylation in mouse models of Alzheimer’s disease
BACKGROUND: Pathological features of Alzheimer’s disease (AD) include aggregation of amyloid beta (Aβ) and tau protein. Macrophage migration inhibitory factor (MIF), a proinflammatory cytokine, has been implicated in the toxicity of aggregated Aβ. It remains unclear whether MIF affects hyperphosphor...
Autores principales: | Li, Shu-Qin, Yu, Yang, Han, Jin-Zhao, Wang, Ding, Liu, Jin, Qian, Feng, Fan, Guo-Huang, Bucala, Richard, Ye, Richard D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4574615/ https://www.ncbi.nlm.nih.gov/pubmed/26382037 http://dx.doi.org/10.1186/s12974-015-0396-3 |
Ejemplares similares
-
Macrophage Migration Inhibitory Factor Deficiency Augments Doxorubicin‐Induced Cardiomyopathy
por: Xu, Xihui, et al.
Publicado: (2013) -
p47(phox) deficiency improves cognitive impairment and attenuates tau hyperphosphorylation in mouse models of AD
por: Gong, Ping, et al.
Publicado: (2020) -
Suppression of LPS-induced tau hyperphosphorylation by serum amyloid A
por: Liu, Jin, et al.
Publicado: (2016) -
Site-Specific Cerebrospinal Fluid Tau Hyperphosphorylation in Response to Alzheimer’s Disease Brain Pathology: Not All Tau Phospho-Sites are Hyperphosphorylated
por: Barthélemy, Nicolas R., et al.
Publicado: (2022) -
Macrophage Migration Inhibitory Factor: Critical Role in Obesity, Insulin Resistance, and Associated Comorbidities
por: Kleemann, Robert, et al.
Publicado: (2010)